Eur Rev Med Pharmacol Sci 2016; 20 (6): 1130-1134

Clinical observation on pericardiocentesis and glucocorticoid in the treatment of tuberculous pericarditis

H. Li, F.-Y. Liu, X.-L. Li, L. Zhu, H. Zhou

Department of Cardiovascularology, Xiangyang Hospital Affiliated to Hubei University of Medicine, Xiangyang, Hubei, China. 3404617lihui@163.com


OBJECTIVE: To investigate peri­cardiocentesis and glucocorticoids in the treat­ment of the clinical curative effect of tubercu­lous pericarditis.

PATIENTS AND METHODS: Choose 128 cases of our hospital diagnosed as tuberculous peri­carditis patients as the research object, accord­ing to the treatment, were divided into group A (pericardium puncture + anti-tuberculosis (an­ti-TB) treatment of 26 cases) and group B (peri­cardium puncture +anti-tuberculosis (anti-TB) + glucocorticoid treatment of 30 cases), group C (anti-tuberculosis (anti-TB) + glucocorticoid therapy of 24 cases, and group D anti-tuberculo­sis (anti-TB) treatment of 48 cases, in the treat­ment of 8 weeks, 3 months, 6 months, 9 months, 12 months, 18 months by B ultrasonic and CT ex­amination to observe the efficacy of treatment.

RESULTS: At 8 weeks after treatment in group A, group B and group C and group D efficient were 61.54%, 93.33%, 54.17%, and 68.75%, respective­ly, group B, respectively, compared with group A, group C, and group D, had obvious statistical sig­nificance difference (p < 0.05); Groups of early and late treatment comparison difference have no sta­tistical significance (p > 0.05).

CONCLUSIONS: Tuberculous pericarditis in anti-TB treatment on the basis of using pericar­diocentesis and sugar cortical hormone treat­ment, can achieve an ideal effect.

Free PDF Download

To cite this article

H. Li, F.-Y. Liu, X.-L. Li, L. Zhu, H. Zhou
Clinical observation on pericardiocentesis and glucocorticoid in the treatment of tuberculous pericarditis

Eur Rev Med Pharmacol Sci
Year: 2016
Vol. 20 - N. 6
Pages: 1130-1134